Combined DNA vaccine and biological modifiers for cancer therapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 3, 2008
Grant Date -
Apr 13, 2006
app pub date -
Apr 24, 2003
filing date -
Apr 26, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to the combination of a DNA vaccination strategy that makes use of a nucleic acid encoding an immunogenic polypeptide, with a non-immunosuppressive inducer of tumor cell differentiation and/or apoptosis or a tumor cell modifier, useful for cancer therapy. Vaccine compositions and kits are provided, as well as specific nucleic acid constructs that are particularly suitable for the preparation of such compositions.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully